Saxenda®(Italian)
$249.99
Description
Saxenda® (liraglutide) injection is an injectable prescription medicine used for adults with excess weight (BMI ≥27) who also have weight-related medical problems or obesity (BMI ≥30), and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off. Saxenda® should be used with a reduced-calorie diet and increased physical activity.
Composition:
The active ingredient, liraglutide
Side Effects:
- Nausea, diarrhea, constipation, vomiting.
- Injection site reactions, headache, dizziness, and fatigue.
- Hypoglycemia (especially in patients with type 2 diabetes).
Packaging:
3 x 3ml Pre-Filled Pen
Specifications
- Main Ingredient:
- Manufacturer: Novo Nordisk
- Drug Class:
- Generic Name:
- Package Contents: 3 mL x 3 Pre-Filled Pen
- Storage Requirements:
- Main Usage:
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
$43.99 - $49.99
Ultra V – UltraCol 200
Dermal Filler
$263.99 - $299.99
StiCol Volume
Dermal Filler
$175.99 - $199.99
Theraset®
Dermal Filler
$175.99 - $199.99
Related Articles
Weight Loss Injections for Next-Level Patient Results
In recent years, weight loss injections have surfaced as a transformative approach in the management…
Profhilo® Injections: Boosting Skin Hydration and Elasticity
As patient demand shifts toward subtle, natural-looking aesthetic enhancements, medical professionals seek advanced solutions beyond…
Cingal Injection: Fast Relief for Knee Osteoarthritis
Knee osteoarthritis is a debilitating condition affecting millions of patients worldwide. As a progressive joint…
Alidya Injections for Cellulite: Effective Skin Treatment
Cellulite is a common concern among individuals, especially women, affecting the appearance and texture of…
ACTEMRA® Injection: Uses, Benefits, and Side Effects
Managing chronic inflammatory conditions remains a challenge for medical practitioners, with autoimmune diseases like rheumatoid…
WEGOVY®: Advancing Obesity Treatment with GLP-1 Therapy
Obesity remains a global health challenge, with rising prevalence and increasing comorbidities such as type…
OZEMPIC® for Weight Loss: Changing Obesity Management
Obesity management has long been a challenge in clinical practice, with limited pharmaceutical interventions that…
MONOVISC® Knee Injection: A Single Shot for Osteoarthritis Relief
Osteoarthritis is a progressive joint disease that impacts millions, causing ongoing discomfort, joint rigidity, and…